Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2010
12/23/2010US20100322955 Virulence genes, proteins, and their use
12/23/2010US20100322950 Compositions and methods for diagnosis and treatment of tumors
12/23/2010US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
12/23/2010US20100322946 Multispecific antibodies
12/23/2010US20100322942 Therapeutic and prophylactic methods for neuromuscular disorders
12/23/2010US20100322941 Human Anti-IP-10 Antibodies Uses Thereof
12/23/2010US20100322939 Novel methods for treating egfr-associated tumors
12/23/2010US20100322938 Novel clusterin derived peptide
12/23/2010US20100322937 EGF receptor epitope peptides and uses thereof
12/23/2010US20100322936 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same
12/23/2010US20100322935 Tri- or Tetraspecific Antibodies
12/23/2010US20100322934 Bispecific, Tetravalent Antigen Binding Proteins
12/23/2010US20100322932 Methods for amyloid removal using anti-amyloid antibodies
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322927 Glycosylated antibodies
12/23/2010US20100322925 Alk7 and myostatin inhibitors and uses thereof
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322919 Antibodies Against a Cancer-Associated Epitope of Variant NFKBIB and Uses Thereof
12/23/2010US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
12/23/2010US20100322851 KID3 and KID3 Antibodies That Bind Thereto
12/23/2010US20100322850 New plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
12/23/2010CA2765989A1 Anti notch-1 antibodies
12/23/2010CA2765755A1 Anti-vegf antibodies and their uses
12/23/2010CA2764545A1 Bace1 inhibitory antibodies
12/23/2010CA2764393A1 Bispecific, tetravalent antigen binding proteins
12/23/2010CA2764392A1 Bispecific antigen binding proteins
12/23/2010CA2761568A1 Structured viral peptide compositions and methods of use
12/23/2010CA2751000A1 Methods of purifying small modular immunopharmaceutical proteins
12/22/2010EP2264464A2 Immunoassays for buprenorphine and norbuprenorphine
12/22/2010EP2264462A1 Method for screening of therapeutic agent for cancer
12/22/2010EP2264191A1 Asymmetrically branched polymer conjugates and microarray assays
12/22/2010EP2264176A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/22/2010EP2264175A1 Fibroblast growth factor homologs
12/22/2010EP2264174A2 Protein similar to neuroendocrine-specific protein, and encoding CDNA
12/22/2010EP2264166A2 Method for controlling the activity of immunologically functional molecule
12/22/2010EP2264163A2 Methods of modifying eukaryotic cells
12/22/2010EP2264152A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function
12/22/2010EP2264151A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function
12/22/2010EP2264073A1 Endothelial cell specific antibodies and uses thereof
12/22/2010EP2264072A1 Enhancement of antibody-mediated cytotoxicity.
12/22/2010EP2264071A1 Antibody having an immune-enhancement function
12/22/2010EP2264070A1 Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263693A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/22/2010EP2263692A1 Anti-NGF antibodies and methods using same
12/22/2010EP2263691A1 Treatment of cancer with the recombinant humanized monoclonal anti-erbb2 antibody 2C4 (rhuMAb 2C4)
12/22/2010EP2263086A2 Biomarkers
12/22/2010EP2262840A2 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/22/2010EP2262839A1 Use of an anti-cd151 antibody for early treatment of cancer
12/22/2010EP2262838A1 Agent for treating disease
12/22/2010EP2262837A2 Pd-1 binding proteins
12/22/2010EP2262836A1 Antibody against the csf-1 r
12/22/2010EP2262835A1 Immunoglobulin compositions and methods of producing same
12/22/2010EP2262834A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/22/2010EP2262833A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
12/22/2010EP2262832A1 Monoclonal antibodies for ebola and marburg viruses
12/22/2010EP2262831A1 Anti-properdin antibodies
12/22/2010EP2262828A1 Compositions, methods and kits
12/22/2010EP2262541A1 C2orf18 as target gene for cancer therapy and diagnosis
12/22/2010EP2262531A1 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
12/22/2010EP2262530A1 Metalloproteinase 12 binding proteins
12/22/2010EP2262529A2 Metalloproteinase 9 binding proteins
12/22/2010EP2164516B1 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
12/22/2010EP2004688B1 Improved protofibril selective antibodies and the use thereof
12/22/2010EP1824886B1 Fully human monoclonal antibodies to il-13
12/22/2010EP1730196B1 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
12/22/2010EP1676862B1 Recombinant antibody against human insulin-like growth factor
12/22/2010EP1664289B1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
12/22/2010EP1561814B1 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
12/22/2010EP1373519B1 New elongase gene and production of delta-9-polyunsaturated fatty acids
12/22/2010EP1135496B1 Ucp5
12/22/2010CN1849136B Cancerous disease modifying antibodies
12/22/2010CN101925819A Immunodetection assay for mycobacterium tuberculosis complex
12/22/2010CN101925612A Antibodies against cancer-associated epitope of variant nfkbib and uses thereof
12/22/2010CN101925611A Wise binding agents and epitopes
12/22/2010CN101925364A 14-3-3 antagonists for prevention and treatment of arthritis
12/22/2010CN101921787A schistosoma japonica adenosine deaminase gene and coding protein and application thereof
12/22/2010CN101921783A Schistosoma japonica L-lactic dehydrogenase gene, encoding protein and application thereof
12/22/2010CN101921782A Schistosoma japonica arginyl transport RNA enzyme gene, encoding protein and application thereof
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921768A Schistosoma japonica 14-3-3 protein gene, coded protein thereof and application thereof
12/22/2010CN101921767A Schistosoma japonica MF3 protein gene, and coding protein and application thereof
12/22/2010CN101921732A A virus causing respiratory tract illness in susceptible mammals
12/22/2010CN101921731A Monoclonal antibody of fluoroquinolone medicines as well as preparation method and application thereof
12/22/2010CN101921730A Monoclonal antibody of ractopamine and preparation method and application thereof
12/22/2010CN101921340A Protein
12/22/2010CN101921338A Gold-binding protein and use thereof
12/22/2010CN101921337A Antibody against lactate dehydrogenase of plasmodium vivax, related preparation method, hybridoma cell strain and application
12/22/2010CN101921336A Monoclonal antibody against human alpha1 acid glycoprotein and preparation method thereof
12/22/2010CN101921335A Hybrid tumor generating anti-AMP-18 (Antrum Mucosalprotein-18) monoclonal antibody as well as anti-AMP-18 monoclonal antibody and application thereof in gastric carcinoma detection
12/22/2010CN101921334A Preparation method of multivalence egg-yolk immunoglobulin for resisting diarrheas
12/22/2010CN101921312A Human HNRPF polypeptide and preparation method of antibody thereof
12/22/2010CN101920004A Preparation and application of coconut globulin ferrous complex iron supplement agent
12/21/2010US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy
12/21/2010US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis
12/21/2010US7855276 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells
12/21/2010US7855275 using antibodies and antibody-drug conjugate compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions; killing or inhibiting the proliferation of tumor cells or cancer cells
12/21/2010US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 1494